GLPBio

Cyclooxygenase

Products Related to Cyclooxygenase(517)

  • GC18830 structure
    GC188302,3-dinor Prostaglandin E1
    CAS: 7046-40-4
    Purity: >98%

    Prostaglandin E1 (PGE1) is not a major naturally occurring prostaglandin, but it is widely administered clinically for several indications including peripheral occlusive vascular disease, erectile dysfunction and in neonatal cardiology.

  • GC18837 structure
    GC18837Carbocyclic Thromboxane A2
    CAS: 74034-56-3
    Purity: >98%

    CTA2 is a stable analog of TXA2.

  • GC18841 structure
    GC188416-keto Prostaglandin F1α-d4
    CAS: 82414-64-0
    Purity: >99.00% deuterated forms (d1-d4)

    6-keto Prostaglandin F1α-d4 (6-keto PGF1α-d4) contains four deuterium atoms at the 3, 3', 4, and 4' positions.

  • GC18855 structure
    GC18855Prostaglandin A1 ethyl ester
    CAS: 93464-24-5
    Purity: >98%

    Prostaglandin A1 (PGA1) ethyl ester is a prodrug form of PGA1 with enhanced lipid solubility.

  • GC18856 structure
    GC18856CAY10526
    CAS: 938069-71-7
    Purity: >98.00%

    CAY10526 ist ein spezifischer Inhibitor der mikrosomalen PGE2-Synthase-1 (mPGES1). CAY10526 hemmt die PGE2-Produktion durch die selektive Modulation der mPGES1-Expression, wirkt sich jedoch nicht auf COX-2 aus. CAY10526 unterdr&Uuml;ckt signifikant das Tumorwachstum und erh&Ouml;ht die Apoptose in Melanom-Xenotransplantaten. CAY10526 reduziert die Proteinspiegel von BCL-2 und BCL-XL (anti-apoptotisch) und erh&Ouml;ht die Spiegel von BAX und BAK (pro-apoptotisch) sowie gespaltener Caspase 3. CAY10526 hemmt die Zelllebensf&Auml;higkeit (IC50<5 μM) in drei Melanom-Zelllinien, die mPGES1 exprimieren.

  • GC18865 structure
    GC18865Prostaglandin F1β
    CAS: 10164-73-5
    Purity: >98%

    PGF1β is the C-9 epimer of PGF1α.

  • GC18874 structure
    GC18874Prostaglandin F2α serinol amide
    CAS: 1135226-99-1

    A stable analog of PGF 2α 2glyceryl ester

  • GC18878 structure
    GC18878Prostaglandin D1 Alcohol
    CAS: 1176470-37-3
    Purity: >98%

    Prostaglandin D1(PGD1) alcohol is the synthetic analog of PGD1 with a primary alcohol in place of the C-1 carboxyl.

  • GC18882 structure
    GC18882AF3485
    CAS: 1195786-61-8
    Purity: >98%

    AF3485 is a selective 3-aminocarbazole inhibitor of mPGES-1, blocking the synthesis of PGE2 but not PGF2α in A549 cells stimulated with IL-1β (IC50s = 2.9 and >100 µM, respectively).

  • GC18893 structure
    GC18893CAY10638
    CAS: 1221413-57-5
    Purity: >98%

    Prostaglandins have a short life in vivo because NAD+-dependent 15-hydroxy prostaglandin dehydrogenase (15-PGDH) catalyzes their oxidation to 15-keto metabolites with greatly reduced biological activity.

  • GC18898 structure
    GC18898CAY10509
    CAS: 1245699-47-1
    Purity: >98%

    The actions of many clinical prostaglandins, including those used for estrous synchronization and for reduction of intraocular pressure, are mediated through the FP receptor.

  • GC18914 structure
    GC18914Prostaglandin F2α Alcohol
    CAS: 13261-27-3
    Purity: >98%

    Prostaglandin F2α alcohol (PGF2α-OH) is an analog of PGF2α in which the C-1 carboxyl group has been reduced to a primary alcohol.

  • GC18920 structure
    GC18920Prostaglandin F1α Alcohol
    CAS: 13487-47-3
    Purity: >98%

    Prostaglandin F1α (PGF1α) alcohol is an analog of PGF1α with a primary alcohol replacing the C-1 carboxyl group.

  • GC18921 structure
    GC18921tetranor-PGJM
    CAS: 1352751-83-7
    Purity: >98%

    Prostaglandin D2 (PGD2) plays a pharmacological role in allergic and asthmatic anaphylaxis, normal physiological sleep and lowering of body temperature, as well as inhibits platelet aggregation and relaxes vascular smooth muscle.

  • GC18999 structure
    GC18999Prostaglandin D1
    CAS: 17968-82-0
    Purity: >98.00%

    Prostaglandin D1 (PGD1) is the theoretical D-series metabolite of DGLA, but to date it has not been isolated as a natural product.

  • GC19462 structure
    GC1946213(R)-HODE
    CAS: 10219-69-9
    Purity: >98.00%

    13(R)-HODE is the opposite enantiomer of the 13(S)-HODE produced when linoleic acid is incubated with soybean lipoxygenase.

  • GC19706 structure
    GC19706Propacetamol hydrochloride
    CAS: 66532-86-3
    Purity: >98%
  • GC20027 structure
    GC20027(±)5(6)-DiHET MaxSpec® Standard
    CAS: 213382-49-1
    Purity: >95.00%

    5(6)-DiHET is a fully racemic version of the enantiomeric forms biosynthesized from 5(6)-EET by epoxide hydrolases.

  • GC40069 structure
    GC40069Teleocidin A1
    CAS: 70497-14-2
    Purity: >98.00%

    Teleocidin A1 (Lyngbyatoxin A), ein hochgiftiger Hautreizstoff, ist ein starker Aktivator der Proteinkinase C (PKC). Teleocidin A1 zeigt antiproliferative Aktivit&Auml;t gegen HeLa-Krebszellen (IC50 = 9,2 nM).

  • GC40239 structure
    GC40239Limaprost-d3
    CAS: 1263190-37-9
    Purity: >99.00%

    Limaprost-d3 is intended for use as an internal standard for the quantification of limaprost by GC- or LC-MS.

  • GC40271 structure
    GC40271(±)5(6)-DiHET MaxSpec® Standard
    CAS: 213382-49-1
    Purity: >95.00%

    5(6)-DiHET is a fully racemic version of the enantiomeric forms biosynthesized from 5(6)-EET by epoxide hydrolases.

  • GC40272 structure
    GC40272(±)8(9)-DiHET
    CAS: 192461-96-4
    Purity: >98.00%

    Epoxide hydrolases convert the EETs into vicinal diols, with the concurrent loss of much of their biological activity.

  • GC40274 structure
    GC4027411-deoxy Prostaglandin F2α
    CAS: 37786-06-4
    Purity: >95.00%

    11-deoxy PGF2α is a synthetic analog of PGF2α.

  • GC40275 structure
    GC4027511-deoxy Prostaglandin F2β
    CAS: 37786-07-5
    Purity: >98.00%

    11-deoxy Prostaglandin F2β (11-deoxy PGF2β) is an analog of PGF2β.